TP53 and breast cancer: Our data showed that ectopic expression of SNORD50A/B in p53wt breast cancer cells dramatically reduced the expression of p53 proteins, while SNORD50A/B knockdown increased p53 protein stability by inhibiting its ubiquitination degradation.